Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.40
-0.1100-7.28%
Volume:69.96K
Turnover:98.97K
Market Cap:34.02M
PE:-6.70
High:1.51
Open:1.50
Low:1.36
Close:1.51
52wk High:5.48
52wk Low:0.6100
Shares:24.30M
Float Shares:21.54M
Volume Ratio:1.75
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2089
EPS(LYR):-0.4200
ROE:-47.71%
ROA:-17.22%
PB:2.82
PE(LYR):-3.33

Loading ...

Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 14, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 07, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 01, 2023

Correspondence

Form CORRESP - Correspondence
Jun 01, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Correspondence

Form CORRESP - Correspondence
May 10, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 24, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 24, 2023

Major Issues Report

8-K - Current report